Alba Mario M, Ebright Brandon, Hua Brittney, Slarve Ielyzaveta, Zhou Yiren, Jia Yunyi, Louie Stan G, Stiles Bangyan L
Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA, Unites States.
Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, CA, Unites States.
Front Physiol. 2023 Feb 2;14:1098467. doi: 10.3389/fphys.2023.1098467. eCollection 2023.
Liver cancer is a malignancy developed from underlying liver disease that encompasses liver injury and metabolic disorders. The progression from these underlying liver disease to cancer is accompanied by chronic inflammatory conditions in which liver macrophages play important roles in orchestrating the inflammatory response. During this process, bioactive lipids produced by hepatocytes and macrophages mediate the inflammatory responses by acting as pro-inflammatory factors, as well as, playing roles in the resolution of inflammation conditions. Here, we review the literature discussing the roles of bioactive lipids in acute and chronic hepatic inflammation and progression to cancer.
肝癌是一种由潜在肝脏疾病发展而来的恶性肿瘤,这些潜在肝脏疾病包括肝损伤和代谢紊乱。从这些潜在肝脏疾病发展为癌症的过程伴随着慢性炎症状态,其中肝脏巨噬细胞在协调炎症反应中发挥重要作用。在此过程中,肝细胞和巨噬细胞产生的生物活性脂质作为促炎因子介导炎症反应,并在炎症状态的消退中发挥作用。在这里,我们回顾了讨论生物活性脂质在急性和慢性肝脏炎症以及癌症进展中作用的文献。